Literature DB >> 17244687

Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1.

Yumi Tone1, Taizo Wada, Fumie Shibata, Tomoko Toma, Yoko Hashida, Yoshihito Kasahara, Shoichi Koizumi, Akihiro Yachie.   

Abstract

Leukocyte adhesion deficiency type 1 (LAD-1) is an autosomal recessive disorder caused by mutations in the ITGB2 (CD18) gene and characterized by recurrent severe infections, impaired pus formation, and defective wound healing. We describe an unusual case of severe phenotypic LAD-1 presenting with somatic mosaicism. The patient is a compound heterozygote bearing 2 different frameshift mutations that abrogate protein expression. However, CD18 expression was detected in a small proportion of T cells but was undetectable in granulocytes, monocytes, B cells, and natural killer (NK) cells. The T cells were not of maternal origin, lacked the paternal mutation, and showed a selective advantage in vivo. Molecular analysis using sorted CD18+ cells revealed them to be derived from a single CD8+ T cell carrying T-cell receptor VB22. These findings suggest that spontaneous in vivo reversion was responsible for the somatic mosaicism in our patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244687     DOI: 10.1182/blood-2007-08-039057

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  Hematologically important mutations: leukocyte adhesion deficiency (first update).

Authors:  Edith van de Vijver; Anne Maddalena; Özden Sanal; Steven M Holland; Gulbu Uzel; Manisha Madkaikar; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Nima Parvaneh; Alain Fischer; S K Alex Law; Nigel Klein; F Ilhan Tezcan; Ekrem Unal; Turkan Patiroglu; Bernd H Belohradsky; Klaus Schwartz; Raz Somech; Taco W Kuijpers; Dirk Roos
Journal:  Blood Cells Mol Dis       Date:  2011-11-30       Impact factor: 3.039

Review 2.  Revertant mosaicism in skin: natural gene therapy.

Authors:  Joey E Lai-Cheong; John A McGrath; Jouni Uitto
Journal:  Trends Mol Med       Date:  2010-12-29       Impact factor: 11.951

3.  Reactive peripheral blood plasmacytosis in a patient with acute hepatitis A.

Authors:  Taizo Wada; Hideaki Maeba; Yasuhiro Ikawa; Yoko Hashida; Akiko Okumura; Fumie Shibata; Yumi Tone; Masayuki Inoue; Shoichi Koizumi; Hajime Takatori; Yoshio Sakai; Shuichi Kaneko; Akihiro Yachie
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

4.  Mutations to the rescue.

Authors:  Mike May
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

5.  Highlighting the problematic reliance on CD18 for diagnosing leukocyte adhesion deficiency type 1.

Authors:  Sarina Levy-Mendelovich; Erez Rechavi; Omar Abuzaitoun; Helly Vernitsky; Amos J Simon; Atar Lev; Raz Somech
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

6.  Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray.

Authors:  D K Bayer; C A Martinez; H S Sorte; L R Forbes; G J Demmler-Harrison; I C Hanson; N M Pearson; L M Noroski; S R Zaki; W J Bellini; M S Leduc; Y Yang; C M Eng; A Patel; O K Rodningen; D M Muzny; R A Gibbs; I M Campbell; C A Shaw; M W Baker; V Zhang; J R Lupski; J S Orange; F O Seeborg; A Stray-Pedersen
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 7.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

8.  Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1).

Authors:  Gulbu Uzel; Emilia Tng; Sergio D Rosenzweig; Amy P Hsu; Jacqueline M Shaw; Mitchell E Horwitz; Gilda F Linton; Stacie M Anderson; Martha R Kirby; Jaõ B Oliveira; Margaret R Brown; Thomas A Fleisher; S K Alex Law; Steven M Holland
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

9.  Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.

Authors:  Thomas R Bauer; Laura M Tuschong; Katherine R Calvo; Heather R Shive; Tanya H Burkholder; Eleanor K Karlsson; Robert R West; David W Russell; Dennis D Hickstein
Journal:  Mol Ther       Date:  2013-03-26       Impact factor: 11.454

10.  Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.

Authors:  Thomas R Bauer; James M Allen; Mehreen Hai; Laura M Tuschong; Iram F Khan; Erik M Olson; Rima L Adler; Tanya H Burkholder; Yu-Chen Gu; David W Russell; Dennis D Hickstein
Journal:  Nat Med       Date:  2007-12-23       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.